Add The Wire As Your Trusted Source
For the best experience, open
https://m.thewire.in
on your mobile browser.
AdvertisementAdvertisement

OMRON Healthcare Surpasses 50 Million Nebulizers Sold

omron healthcare surpasses 50 million nebulizers sold
Advertisement

KYOTO, Japan, Nov. 28, 2025 /Kyodo JBN/ --

- Easing Burden of Respiratory Diseases Worldwide since 1978 -

OMRON HEALTHCARE Co., Ltd., a global leader in the field of clinically proven, innovative medical equipment for home health monitoring and treatment, announced that cumulative sales of its nebulizers have surpassed 50 million units. This proud milestone underscores the company’s long-standing commitment to helping people around the world to live healthier lives through management of respiratory conditions.

Image1: https://cdn.kyodonewsprwire.jp/prwfile/release/M000242/202510308084/_prw_PI1fl_gvhJ3KRi.png

Internationally, respiratory diseases are a growing issue, particularly in emerging economies. According to the World Health Organization, some 339 million people suffer from asthma worldwide, with an estimated 3.5 million deaths each year due to Chronic Obstructive Pulmonary Disorder (COPD). Nebulizers, which convert liquid medications into a fine mist that can be inhaled directly into the lungs, are a key tool for easing the burden of respiratory diseases in children and adults alike.

Advertisement

Almost five decades as a trusted partner in respiratory therapy

Since the launch of its first nebulizer in 1978, OMRON Healthcare has pioneered the development of compact home-use devices that deliver medical-grade respiratory treatment outside of clinical settings, prioritizing ease of use for families and patients of all ages, from young children to older adults.

Advertisement

Image2: https://cdn.kyodonewsprwire.jp/prwfile/release/M000242/202510308084/_prw_PI2fl_5D7pQUoU.png

Design landmarks ranging from the first ultrasonic models to portable mesh-type and low-noise compressor technologies have made medication delivery more consistent and convenient for millions of users worldwide, including those living with chronic and acute respiratory ailments such as asthma, COPD, RSV bronchitis, cystic fibrosis, and a range of physical disabilities.

Advertisement

Image3: https://cdn.kyodonewsprwire.jp/prwfile/release/M000242/202510308084/_prw_PI3fl_C3N67qeX.png

Advertisement

Comment from Tomohiro Kukita, Senior Manager, Product Planning Strategy HQ of OMRON HEALTHCARE Co., Ltd.: https://kyodonewsprwire.jp/attach/202510308084-O1-S6J3q6El.pdf
About OMRON Healthcare: https://kyodonewsprwire.jp/attach/202510308084-O2-W1MisE02.pdf

For more information, please visit:

Website: https://healthcare.omron.com/

LinkedIn: https://www.linkedin.com/company/omron-healthcare-co-ltd-/

Source: OMRON HEALTHCARE Co., Ltd.

(Disclaimer: The above press release comes to you under an arrangement with Asianet and PTI takes no editorial responsibility for the same.). PTI

This is an auto-published feed from PTI with no editorial input from The Wire.

This article went live on November twenty-eighth, two thousand twenty five, at twenty-three minutes past four in the afternoon.
Advertisement
Advertisement
tlbr_img1 Series tlbr_img2 Columns tlbr_img3 Multimedia